# Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer

> **NCT00155883** · PHASE2 · TERMINATED · sponsor: **National Taiwan University Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Taxteral
- **DRUG:** 5-Fluorouracil
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT00155883
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 54 (ESTIMATED)
- **Why stopped:** slow a accrul due to many competitive trials.
- **Last updated:** 2008-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00155883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00155883, "Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00155883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*